30 November 2017 | News
Prostate Cancer remains a low priority on the healthcare agendas of most Asian Countries
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacific Prostate Cancer Patient Coalition with the goal to address the challenges faced by men living with prostate cancer and to improve patient outcomes across the region.
The newly formed Prostate Cancer Patient Coalition – Asia PacificTM which includes representatives from Australia, China, Korean, Japan and Taiwan, has marked November, a month dedicated to awareness around men’s health with a focus on prostate cancer, with the launch of the Prostate Cancer Asia Pacific Whitepaper Report – A united voice for change.
Dr. Weng Ho Chow, Vice President, Asia Pacific Medical Affairs, said the company was proud to be a part of such an important and unique initiative. “Janssen is committed to supporting men living with prostate cancer and to help them achieve better health outcomes”, said Dr. Chow.
The inaugural meeting of the Coalition took place earlier this year and was co-chaired by Dr. Koichiro Akakura, Department of Urology, Japan Community Health Care Organization, Tokyo Shinjuku Medical Centre, Japan, and Professor Damien Bolton, Clinical Professor, University of Melbourne, Department of Surgery and Head of Austin Urology Unit, Australia. The whitepaper was the outcome of the discussions from this meeting.